Edwards Lifesciences Corporation will discuss the company’s sharpened focus and strategy for longer-term growth, provide an update on its technology pipeline and share financial guidance1 today.
Edwards Lifesciences (EW) sees FY24 adjusted earnings per share of $2 70 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ HeartValveSurgery.com, a leading patient advocacy group, is teaming up with the Smidt Heart Institute at Cedars-Sinai and Penn Medicine Heart.
/PRNewswire/ Edwards Lifesciences Corporation (NYSE: EW) will discuss the company s strategy for longer-term growth, provide an update on its technology.
Hearts from donors who were Covid positive may be safe for transplantation miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.